Simon R. Dixon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Simon R. Dixon has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Ajitha Raju
1 shared publication- Cindy L. Grines
William Beaumont Hospital, Royal Oak, Michigan
1 shared publication - Darshil Shah
Hematology and Bone and Marrow Transplantation, University of Kentucky, Lexington, USA
1 shared publication Donald S Baim
1 shared publicationEberhard Grube
1 shared publicationGary L Schaer
1 shared publication
Latest Publications
- 1 October 2007
- Published by Elsevier in The American Journal of Cardiology
- Vol. 100 (7) , 1090-1093
Comparison of the Usefulness of Gadodiamide and Iodine Mixture Versus Iodinated Contrast Alone for Prevention of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease Undergoing Coronary Angiography
- 1 October 2007
- Published by Elsevier in The American Journal of Cardiology
- Vol. 100 (7) , 1090-1093
Comparison of the Usefulness of Gadodiamide and Iodine Mixture Versus Iodinated Contrast Alone for Prevention of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease Undergoing Coronary Angiography
- 1 July 2006
- p. 17C-21C
Safety of AngioJet thrombectomy in acute ST-segment elevation myocardial infarction: a large, single-center experience.
To determine the clinical outcomes associated with use of AngioJet thrombectomy (AT) during percutaneous coronary intervention (PCI) for acute ST-segment elevation myocardial infarction (STEMI). Embolization of thrombus and atherosclerotic plaque is thought to contribute to sub-optimal myocardial reperfusion and worse clinical outcomes in STEMI. However, in a recent randomized trial, a higher mortality and infarct size was observed in patients treated with AT. We performed a retrospective analysis of all patients who underwent primary or rescue PCI for STEMI between January 2000 and December 2005. Angiographic, procedural and in-hospital outcomes were compared between patients treated with or without AT. 1,260 STEMI patients underwent primary or rescue PCI at our hospital during the study period. Of these, 239 (19%) underwent adjunctive treatment with AT. Patients treated with AT were more likely to be female, smokers and have a right coronary artery culprit. A slightly lower incidence of thrombolysis in myocardial infarction (TIMI) 3 grade flow was observed in the AT group after PCI (86% vs. 90%, p = 0.04). There was no significant difference in the incidence of in-lab ventricular tachycardia/ventricular fibrillation, vascular complications or transfusion between the study groups. The peak creatine kinase was higher in patients treated with AT. The incidence of in-hospital major adverse cardiac events was 7.5% in the AT group and 9.0% in the control group (p = NS). In this large, single-center experience, use of AT during mechanical reperfusion for STEMI was not associated with an increased risk of adverse outcomes. Our data suggest that AT may be performed safely in selected patients with STEMI.
- 1 July 2006
- p. 17C-21C
Safety of AngioJet thrombectomy in acute ST-segment elevation myocardial infarction: a large, single-center experience.
To determine the clinical outcomes associated with use of AngioJet thrombectomy (AT) during percutaneous coronary intervention (PCI) for acute ST-segment elevation myocardial infarction (STEMI). Embolization of thrombus and atherosclerotic plaque is thought to contribute to sub-optimal myocardial reperfusion and worse clinical outcomes in STEMI. However, in a recent randomized trial, a higher mortality and infarct size was observed in patients treated with AT. We performed a retrospective analysis of all patients who underwent primary or rescue PCI for STEMI between January 2000 and December 2005. Angiographic, procedural and in-hospital outcomes were compared between patients treated with or without AT. 1,260 STEMI patients underwent primary or rescue PCI at our hospital during the study period. Of these, 239 (19%) underwent adjunctive treatment with AT. Patients treated with AT were more likely to be female, smokers and have a right coronary artery culprit. A slightly lower incidence of thrombolysis in myocardial infarction (TIMI) 3 grade flow was observed in the AT group after PCI (86% vs. 90%, p = 0.04). There was no significant difference in the incidence of in-lab ventricular tachycardia/ventricular fibrillation, vascular complications or transfusion between the study groups. The peak creatine kinase was higher in patients treated with AT. The incidence of in-hospital major adverse cardiac events was 7.5% in the AT group and 9.0% in the control group (p = NS). In this large, single-center experience, use of AT during mechanical reperfusion for STEMI was not associated with an increased risk of adverse outcomes. Our data suggest that AT may be performed safely in selected patients with STEMI.
- 27 January 2003
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 58 (2) , 168-174
Lesion length assessment using a new vessel caliper
- 27 January 2003
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 58 (2) , 168-174
Lesion length assessment using a new vessel caliper